Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.
about
P1343
Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancerTumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakinessPatient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic targetTranslation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonizationA quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness.Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC)PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity.Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.A novel method for gene expression mapping of metastatic competence in human bladder cancerNeuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.The role of PTEN in prostate cancer cell tropism to the bone micro-environment.Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis.Current animal models of bladder cancer: Awareness of translatability (Review)Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.Cross-contamination of a UROtsa stock with T24 cells--molecular comparison of different cell lines and stocksSortilin regulates progranulin action in castration-resistant prostate cancer cellsCD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition.Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease.Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumoursSuppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin.Cheliensisin A (Chel A) induces apoptosis in human bladder cancer cells by promoting PHLPP2 protein degradation.RhoGDIβ Promotes Sp1/MMP-2 Expression and Bladder Cancer Invasion Through Perturbing miR-200c-Targeted JNK2 Protein Translation.Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145.Divergent behaviors and underlying mechanisms of cell migration and invasion in non-metastatic T24 and its metastatic derivative T24T bladder cancer cell linesGenomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer.Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation In Vivo and Human Bladder Cancer Invasion In Vitro by Targeting STAT1/FOXO1 Axis.NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein.Reduced expression of Rho GDP dissociation inhibitor 2 mRNA is associated with lymph node metastasis in gastric carcinoma.Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.
P2860
Q24623746-A0FD39CD-0BB3-4770-B853-DB75856C052BQ27303307-D83D5B86-E89C-47D4-92B6-54C1EF3434E5Q30279180-83266126-6615-4EC8-A2A3-E0F3E9FE0E43Q30408689-3A974B26-1E59-48B4-B645-B95EA3B79202Q30415154-9659A7E1-5213-4B39-8418-66EEB2FE038DQ30416020-C6B91AC4-FF1C-45D8-AC15-9F282CF420D6Q30422907-D92C6257-31BC-4CCF-9CFE-8234ABBD2A3BQ30433431-0580D055-A598-4F56-953B-294B5CF32964Q30434033-CF7BE038-4D96-4D3D-A43B-CA325A4AC26AQ30439008-B1E46CDE-1113-409A-AF76-654BDB15F295Q30440217-6D150294-94BB-486F-9A95-B743D37266C7Q30441149-EA15767C-86A4-44E8-A990-2E6EAB530DC5Q30443138-DDE74B59-D48B-40AE-BE23-EB9C4C313AD0Q30459452-2F957256-9D1B-495C-AB5D-E9687F4FA142Q33635341-66169765-468E-4BFE-BDD0-9C9DFC962576Q33962620-081188A6-6CFB-4247-B498-B2C10DFD74EEQ34199816-C0084997-ED43-4493-A70D-57D183508C8EQ34731286-908B1ED9-D6CE-4BC7-A4E8-7F29841460C8Q34745270-246C7497-A8E2-4CB9-8028-F20500F8E641Q35742418-E48EC885-3E51-4FB3-8E8E-D248EAB49BEAQ36087194-B0653A9B-5147-43C2-9914-C7B568464FCCQ36621389-F8CE35FC-5082-479A-A81C-57B0C6657C11Q37457751-D9B6100A-5554-438F-BEC6-4F6058C52BF8Q37687057-475250D0-EA02-486C-BD7B-C1CD71BC066DQ38605628-E127F416-ED34-4480-A837-D7D4AD03D9A2Q38715437-F839EB6A-0646-455B-A1AE-788E8E8EA326Q38939993-7CB8AB13-E7C6-44DE-B3A1-B9BFE3009489Q39031180-E720DEE8-2512-4769-9010-A0D9426CFB99Q39849534-9249F860-9240-40AC-94A4-FEA4AE2F57D7Q41218420-40E91580-FC42-4223-A043-6E550A07D7C9Q41786785-21F2C516-83AF-4567-9F38-F49AC3AD5ECFQ47157361-6AC1AFDC-3929-485B-A93B-DDD10106BD4D
P2860
Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Genetic and phenotypic changes ...... icity in human bladder cancer.
@ast
Genetic and phenotypic changes ...... icity in human bladder cancer.
@en
type
label
Genetic and phenotypic changes ...... icity in human bladder cancer.
@ast
Genetic and phenotypic changes ...... icity in human bladder cancer.
@en
prefLabel
Genetic and phenotypic changes ...... icity in human bladder cancer.
@ast
Genetic and phenotypic changes ...... icity in human bladder cancer.
@en
P2093
P2860
P1476
Genetic and phenotypic changes ...... nicity in human bladder cancer
@en
P2093
D Theodorescu
J J Gildea
W L Golden
P2860
P304
P356
10.1002/(SICI)1098-2264(200003)27:3<252::AID-GCC5>3.0.CO;2-9
P4510
P577
2000-03-01T00:00:00Z